logo
Plus   Neg
Share
Email

Alnylam Pharma Q3 Loss Narrows On Strong Revenue Growth

Alnylam Pharmaceuticals Inc. (ALNY) reported Thursday that its third-quarter net loss narrowed to $208.5 million or $1.92 per share from last year's loss of $245.3 million or $2.43 per share last year.

Adjusted net loss was $162.5 million, or $1.50 per share, compared to net loss of $157.3 million, or $1.56 per share a year earlier.

Total revenues surged to $70.06 million from $2.07 billion a year ago.

In pre-market activity, Alnylam shares were gaining around 1.4 percent to trade at $88.50.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Procter & Gamble Company (PG) reported that its second-quarter core earnings per share rose 14 percent year-on-year, due to lower non-core restructuring charges versus the prior year. Currency-neutral core earnings per share increased 15 percent. Organic sales were up five percent, for the quarter.... While reporting financial results for the fourth quarter on Thursday, JetBlue Airways Corp. (JBLU) provided its financial outlook for the first quarter and the full-year 2020. For the first quarter, the company expects earnings in a range of $0.10 to $0.20 per share. Capacity is expected to increase... Five Star Food Inc. is recalling certain Sham Gardens Excellent tahina containers for potential contamination with Salmonella, the US Food and Drug Administration said in a statement. The recall involves 100 cases of Excellent tahina 800 g and 100 cases of Excellent tahina 400 g containers. The Garden City, Michigan-based company, however, has not received any reports of illness.
Follow RTT
>